FSH and bone - important physiology or not?

Trends in Molecular Medicine

Volumn 13, Issue 1, 2007, Pages 1-3

  Prior, Jerilynn C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; ESTROGEN DEFICIENCY; HETEROZYGOTE; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPOGONADISM; IMAGE ANALYSIS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; SHORT SURVEY; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL;

BONE RESORPTION; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MODELS, BIOLOGICAL; OSTEOPOROSIS, POSTMENOPAUSAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845868566     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.11.004     Document Type: Short Survey

References (19)

1. Sun L., et al. FSH directly regulates bone mass. Cell 125 (2006) 247-260
2. Iqbal J., et al. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14925-14930
3. Baron R. FSH versus estrogen: who's guilty of breaking bones?. Cell Metab. 3 (2006) 302-305
4. Martin T.J., and Gaddy D. Bone loss goes beyond estrogen. Nat. Med. 12 (2006) 612-613
5. Prior J.C. Perimenopause: the complex endocrinology of the menopausal transition. Endocr. Rev. 19 (1998) 397-428
6. Danilovich N., et al. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141 (2000) 4295-4308
7. Kasperk C.H., et al. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124 (1989) 1576-1578
8. Danilovich N., and Sairam M.R. Haploinsufficiency of the follicle-stimulating hormone receptor accelerates oocyte loss inducing early reproductive senescence and biological aging in mice. Biol. Reprod. 67 (2002) 361-369
9. Kuhn T.S. The structure of scientific revolution. 1st ed. (1970), University of Chicago Press
10. Petit M.A., and Prior J.C. Exercise and the hypothalamus: ovulatory adaptions. In: Warren M.P., and Constantin N.W. (Eds). Sports Endocrinology (2000), Humana Press, Inc. 133-163
11. Biller B.M., et al. Osteopenia in women with hypothalamic amenorrhea: a prospective study. Obstet. Gynecol. 78 (1991) 996-1001
12. Smith M.R., et al. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N. Engl. J. Med. 345 (2001) 948-955
13. Genant H.K., et al. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann. Intern. Med. 97 (1982) 699-705
14. Eriksen E.F., et al. Evidence of estrogen-receptors in normal human osteoblast-like cells. Science 241 (1988) 84-86
15. Abe T., et al. Estrogen does not restore bone lost after ovariectomy in the rat. J. Bone Min. Res. 8 (1993) 831-838
16. Prior J.C., et al. Spinal bone loss and ovulatory disturbances. N. Engl. J. Med. 323 (1990) 1221-1227
17. Sowers M., et al. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass. J. Bone Min. Res. 13 (1998) 1191-1202
18. Prior J.C., et al. Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances. Am. J. Med. 96 (1994) 521-530
19. Polatti F., et al. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 51 (1995) 221-224